Hadassah

Pregnant Woman from Cyprus with Rare Ectopic Pregnancy Saved at Hadassah

Wednesday, Apr 25 2012

Prof. David Linton, Director of Hadassah’s Internal Medicine Intensive Care Unit, who is also a pilot, flew to Cyprus with a Hadassah team and brought the woman to Hadassah. Following a series of tests, Hadassah’s obstetricians confirmed that the fetus was not in the woman’s uterus, nor in her Fallopian tube; instead, the fetus was retroperitoneal (underneath the tissue covering the inner side of the abdomen). According to the medical literature, this is only the second case of such an ectopic pregnancy ever reported!

Because the growing fetus could tear the woman’s blood vessels in the area and cause massive intra-abdominal bleeding, it was necessary to terminate the pregnancy. When the woman began to bleed heavily following the termination, vascular surgeons and radiologists were called in. They discovered that the ectopic pregnancy had already damaged several blood vessels and penetrated the envelope of her abdomen. The Hadassah team was, however, able to control the bleeding and save the woman's life without damaging her kidney. “The multidisciplinary approach was crucial to the success of the treatment,” explains Prof. Neri Laufer, Chair of Hadassah’s Department of Obstetrics and Gynecology.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Hadassah Removes Tumor;
Gazan Boy Walks for First Time

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More